Found: 16
Select item for more details and to access through your institution.
Clinical Response to Pazopanib in a Patient With KDR-Mutated Metastatic Basal Cell Carcinoma.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Interpretation of ambiguous TP53 test results: Mosaicism, clonal hematopoiesis, and variants of uncertain significance.
- Published in:
- Journal of Genetic Counseling, 2024, v. 33, n. 4, p. 916, doi. 10.1002/jgc4.1789
- By:
- Publication type:
- Article
Large granular lymphocytic leukemia – A retrospective study of 319 cases.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 7, p. 772, doi. 10.1002/ajh.26183
- By:
- Publication type:
- Article
Novel and Expanded Oncology Drug Approvals of 2016: PART 2: New Options in the Management of Hematologic Malignancies.
- Published in:
- Oncology (08909091), 2017, v. 31, n. 2, p. 138
- By:
- Publication type:
- Article
Novel and Expanded Oncology Drug Approvals of 2016: PART 1: New Options in Solid Tumor Management.
- Published in:
- Oncology (08909091), 2017, v. 31, n. 2, p. 110
- By:
- Publication type:
- Article
Copy Number Alterations as Novel Biomarkers and Therapeutic Targets in Colorectal Cancer.
- Published in:
- Cancers, 2022, v. 14, n. 9, p. N.PAG, doi. 10.3390/cancers14092223
- By:
- Publication type:
- Article
Association of Age With Treatment-Related Adverse Events and Survival in Patients With Metastatic Colorectal Cancer.
- Published in:
- JAMA Network Open, 2023, v. 6, n. 6, p. e2320035, doi. 10.1001/jamanetworkopen.2023.20035
- By:
- Publication type:
- Article
An analysis of the use of targeted therapies in patients with advanced Merkel cell carcinoma and an evaluation of genomic correlates of response.
- Published in:
- Cancer Medicine, 2021, v. 10, n. 17, p. 5889, doi. 10.1002/cam4.4138
- By:
- Publication type:
- Article
Clinical Pharmacology Worldwide: A Global Health Perspective.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 110, n. 4, p. 946, doi. 10.1002/cpt.2274
- By:
- Publication type:
- Article
Developing Drugs for Tissue‐Agnostic Indications: A Paradigm Shift in Leveraging Cancer Biology for Precision Medicine.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 109, n. 2, p. 334, doi. 10.1002/cpt.1946
- By:
- Publication type:
- Article
Demographic Composition of Select Oncologic New Molecular Entities Approved by the FDA Between 2008 and 2017.
- Published in:
- Clinical Pharmacology & Therapeutics, 2018, v. 104, n. 5, p. 940, doi. 10.1002/cpt.1180
- By:
- Publication type:
- Article
Quantitation of Targetable Somatic Mutations Among Patients Evaluated by a Personalized Medicine Clinical Service: Considerations for Off-Label Drug Use.
- Published in:
- Pharmacotherapy, 2017, v. 37, n. 9, p. 1043, doi. 10.1002/phar.1917
- By:
- Publication type:
- Article
Prognostic and Predictive Value of PIK3CA Mutations in Metastatic Colorectal Cancer.
- Published in:
- Targeted Oncology, 2022, v. 17, n. 4, p. 483, doi. 10.1007/s11523-022-00898-7
- By:
- Publication type:
- Article
Evaluation of Targeted Next-Generation Sequencing for the Management of Patients Diagnosed with a Cancer of Unknown Primary.
- Published in:
- Oncologist, 2022, v. 27, n. 1, p. e9, doi. 10.1093/oncolo/oyab014
- By:
- Publication type:
- Article
Key Lessons Learned from Moffitt's Molecular Tumor Board: The Clinical Genomics Action Committee Experience.
- Published in:
- Oncologist, 2017, v. 22, n. 2, p. 144, doi. 10.1634/theoncologist.2016-0195
- By:
- Publication type:
- Article
Molecular annotation of extramedullary acute myeloid leukemia identifies high prevalence of targetable mutations.
- Published in:
- Cancer (0008543X), 2022, v. 128, n. 21, p. 3880, doi. 10.1002/cncr.34459
- By:
- Publication type:
- Article